Key PointsBoxer Capital Management increased its Vir Biotechnology stake by 1,241,000 shares in the first quarter; the estimated trade size was $9.89 million.Meanwhile, the quarter-end position value rose by $12.95 million, reflecting both share purchases and stock price movements.The transaction represented a 1.3% change in the fund’s 13F reportable assets under management (AUM)Post-trade, the fund holds 1,866,000 Vir Biotechnology shares value…